The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).

NAActive, not recruitingINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

March 8, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2030

Conditions
Mitral Annular CalcificationMitral StenosisMitral RegurgitationMitral Valve Disease
Interventions
DEVICE

Transseptal ViMAC

Transseptal TMVR using balloon-expandable aortic transcatheter valves.

Trial Locations (17)

10032

Columbia University Medical Center/NYPH, New York

14080

Ignacio Chávez National Institute of Cardiology, Mexico City

23507

The Sentara Heart Valve and Structural Disease Center, Norfolk

55905

Mayo Clinic, Rochester

74104

Oklahoma Heart Institute Utica Office, Tulsa

78229

University of Texas Health Science Center at San Antonio, San Antonio

80528

Uchealth Heart & Vascular Clinic Harmony Campus, Fort Collins

84107

Intermountain Medical Center, Murray

85006

Banner - University Medicine Cardiology Clinic, Pheonix

85297

Dignity Health Chandler Regional Medical Center, Gilbert

85712

Pima Heart & Vascular, Tucson

90048

Cedars-Sinai Medical Center, Los Angeles

94109

Sutter Health, San Francisco

97239

Oregon Health & Science University, Portland

200100

Medstar Washington Hospital Center, Washington D.C.

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Mayra Guerrero

OTHER